Global Acromegaly and Gigantism Treatment Market to Reach US$ 2.75 Billion by 2034: Key Growth Drivers
Acromegaly and gigantism are rare endocrine disorders primarily associated with excessive production of growth hormone, often resulting from abnormalities involving the pituitary gland. These conditions can cause progressive changes in physical appearance, metabolic complications, cardiovascular risks, musculoskeletal abnormalities, and other health concerns. Growing awareness of hormonal...
0 Comments 0 Shares 32 Views 0 Reviews